| Primary |
| Menorrhagia |
45.0% |
| Product Used For Unknown Indication |
14.7% |
| Uterine Haemorrhage |
5.4% |
| Haemorrhage |
4.7% |
| Anaesthesia |
3.1% |
| Acute Promyelocytic Leukaemia |
2.3% |
| Anticoagulation Drug Level |
2.3% |
| Dysmenorrhoea |
2.3% |
| Haemoptysis |
2.3% |
| Resuscitation |
2.3% |
| Anticoagulant Therapy |
1.6% |
| Cardiopulmonary Bypass |
1.6% |
| Contraception |
1.6% |
| Gastrointestinal Haemorrhage |
1.6% |
| Haemorrhage Prophylaxis |
1.6% |
| Knee Arthroplasty |
1.6% |
| Lower Respiratory Tract Infection |
1.6% |
| Partial Seizures |
1.6% |
| Post Procedural Haemorrhage |
1.6% |
| Procedural Haemorrhage |
1.6% |
|
| Pulmonary Embolism |
21.8% |
| Grand Mal Convulsion |
19.1% |
| Deep Vein Thrombosis |
8.2% |
| Convulsion |
7.3% |
| Thrombosis |
4.5% |
| Headache |
3.6% |
| Myoclonic Epilepsy |
3.6% |
| Status Epilepticus |
3.6% |
| Toxic Epidermal Necrolysis |
3.6% |
| Cerebrovascular Accident |
2.7% |
| Chest Pain |
2.7% |
| Myocardial Infarction |
2.7% |
| Transient Ischaemic Attack |
2.7% |
| Vomiting |
2.7% |
| Epilepsy |
1.8% |
| Eye Disorder |
1.8% |
| Ischaemic Stroke |
1.8% |
| Pallor |
1.8% |
| Rash |
1.8% |
| Respiratory Failure |
1.8% |
|
| Secondary |
| Product Used For Unknown Indication |
27.8% |
| Idiopathic Thrombocytopenic Purpura |
13.0% |
| Haematology Test Abnormal |
12.3% |
| Gastrooesophageal Reflux Prophylaxis |
10.8% |
| Antiemetic Supportive Care |
9.3% |
| Drug Use For Unknown Indication |
4.2% |
| Drug Exposure During Pregnancy |
2.7% |
| Gastrointestinal Haemorrhage |
2.6% |
| General Anaesthesia |
2.2% |
| Autoimmune Thrombocytopenia |
2.1% |
| Prophylaxis |
1.9% |
| Pharyngitis |
1.6% |
| Haemorrhage |
1.5% |
| Nasopharyngitis |
1.5% |
| Gastric Cancer |
1.4% |
| Haemostasis |
1.1% |
| Otitis Media Acute |
1.1% |
| Factor Viii Deficiency |
1.0% |
| Factor Viii Inhibition |
1.0% |
| Haemorrhage Prophylaxis |
1.0% |
|
| Vaginal Haemorrhage |
12.3% |
| Rectal Haemorrhage |
11.7% |
| Haemoglobin Decreased |
8.6% |
| Rash Maculo-papular |
8.0% |
| Haemorrhage |
7.4% |
| Purpura |
7.4% |
| Sepsis |
6.8% |
| Convulsion |
5.6% |
| Rash Erythematous |
4.9% |
| Melaena |
4.3% |
| Blood Blister |
3.1% |
| Anaphylactic Shock |
2.5% |
| Liver Disorder |
2.5% |
| Oesophageal Atresia |
2.5% |
| Pulmonary Embolism |
2.5% |
| Thrombocytopenia |
2.5% |
| Arthralgia |
1.9% |
| Cerebral Infarction |
1.9% |
| Drug Ineffective |
1.9% |
| Dyspnoea |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
19.2% |
| Prophylaxis |
19.2% |
| Drug Use For Unknown Indication |
9.3% |
| Aplastic Anaemia |
5.4% |
| Cough |
4.2% |
| Acute Myeloid Leukaemia |
3.9% |
| Constipation |
3.6% |
| Infection Prophylaxis |
3.5% |
| Dehydration |
3.3% |
| Nausea |
3.3% |
| Colorectal Cancer |
2.9% |
| Hypertension |
2.9% |
| Fluid Replacement |
2.8% |
| Pain |
2.6% |
| Myelodysplastic Syndrome |
2.6% |
| Depression |
2.4% |
| Medication Dilution |
2.4% |
| Nasopharyngitis |
2.3% |
| Rheumatoid Arthritis |
2.2% |
| Idiopathic Thrombocytopenic Purpura |
2.1% |
|
| White Blood Cell Count Decreased |
9.7% |
| Pneumonia |
8.8% |
| Sepsis |
8.1% |
| Thrombocytopenia |
7.1% |
| Pyrexia |
6.8% |
| Renal Failure Acute |
6.5% |
| Fatigue |
5.5% |
| Platelet Count Increased |
4.9% |
| Septic Shock |
4.9% |
| Vomiting |
4.9% |
| Rash |
4.5% |
| Febrile Neutropenia |
4.2% |
| Platelet Count Decreased |
3.6% |
| Renal Failure |
3.2% |
| Renal Impairment |
3.2% |
| Acute Respiratory Distress Syndrome |
2.9% |
| Anaemia |
2.9% |
| Bradycardia |
2.9% |
| Cerebral Haemorrhage |
2.6% |
| Respiratory Failure |
2.6% |
|
| Interacting |
| Drug Use For Unknown Indication |
26.7% |
| Nasopharyngitis |
20.0% |
| Hyperlipidaemia |
10.0% |
| Hyperuricaemia |
6.7% |
| Thrombosis Prophylaxis |
6.7% |
| Cardiac Disorder |
3.3% |
| Depression |
3.3% |
| Insomnia |
3.3% |
| Knee Arthroplasty |
3.3% |
| Menorrhagia |
3.3% |
| Product Used For Unknown Indication |
3.3% |
| Supraventricular Tachycardia |
3.3% |
| Vertigo |
3.3% |
| Vitamin D Deficiency |
3.3% |
|
| Increased Tendency To Bruise |
33.3% |
| Drug Interaction |
16.7% |
| Menorrhagia |
16.7% |
| Myalgia |
16.7% |
| Pulmonary Embolism |
16.7% |
|
